In agreement with our previous results [26], Aurora-A-induced drug resistance was linked to phosphorylation of SMAD5, a key transcription factor downstream of TGF-b/BMP signaling involved in tumor progression [51, 52]. Here, SMAD5 is linked to neoplasm.